| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2850850 | American Heart Journal | 2011 | 9 Pages |
Abstract
Treatment with n3-PUFA for 3 months exerts a dose-dependent increase of LVEF in patients with CHF. In parallel, a significant improvement of endothelial function and decrease of interleukin 6 is found with high-dose n3-PUFA intervention.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Deddo MD, Alexandra MD, Sabine MD, Raisa MD, Karin MD, Rudolf MD,